PRACTICE QUESTIONS FOR SOCRA EXAM 300
ACTUAL QUESTIONS AND CORRECT ANSWERS
WITH RATIONALE LATEST UPDATE ALREADY
GRADED A+ ASSURED PASS
This comprehensive question bank of 300 unique, multiple-choice questions is
meticulously designed for the SOCRA CCRP certification exam, covering all
major content domains including Research Study Start-Up (40%),
Implementation (50%), and Closure (10%). It rigorously tests knowledge of
ICH GCP E6(R2), FDA regulations (21 CFR Parts 11, 50, 56, 312, 812),
ethical principles from the Belmont Report and Declaration of Helsinki,
informed consent, adverse event reporting, investigational product
accountability, monitoring, and essential documentation. Each question
includes a correct answer and detailed rationale, providing deep conceptual
understanding and exam-style practice for successful certification
preparation.
1. The sponsor withdrew an IND due to safety concerns. Who must be notified
promptly, in addition to the FDA?
A) Site coordinator only
B) Investigational pharmacies only
C) OHRP only
D) Reviewing IRBs/IECs and all participating investigators
Answer: D
Rationale: According to 21 CFR 312.56(d), if an IND is withdrawn for safety, the
sponsor must notify the FDA and all participating investigators, who in turn notify
their reviewing IRBs/IECs. This ensures subjects are protected and sites stop
enrollment promptly .
2. A coordinator for an ongoing industry-sponsored, multi-site Phase II clinical
trial is taking an unexpected, long-term medical absence. The trial site retains
coordinator services from an external source to support clinical trial activities.
According to ICH GCP E6(R2), who is responsible for implementing procedures
to ensure the integrity of the clinical trial-related duties?
A) The sponsor
B) The investigator/institution
,C) The IRB/IEC
D) The external source
Answer: B
Rationale: The investigator/institution bears responsibility for site conduct,
oversight of delegated tasks, and ensuring qualified, trained staff regardless of
employment source. ICH E6(R2) 4.1.1 requires the investigator to be qualified and
have adequate resources, and 4.1.5 requires ensuring all assisting persons are
adequately informed about the protocol and their duties. Section 4.2.5 states the
investigator may delegate tasks but retains responsibility for the conduct of the trial
at the site .
3. In accordance with the CFR, for at least how many years after the completion of
a study must the clinical investigator provide the sponsor with relevant changes to
financial information?
A) One year
B) Two years
C) Three years
D) Five years
Answer: A
Rationale: 21 CFR 54.4(b) requires sponsors to collect financial disclosure
information before a study begins and for one year following completion. 21 CFR
54.6(e) requires clinical investigators to update financial disclosure information
during the study and for one year following completion .
4. During an IND study closeout, a monitor discovered remaining investigational
product. Which procedures must be followed for disposition?
A) IRB/IEC's procedures
B) Sponsor's procedures
C) Regulatory authority's procedures
D) Dispensing pharmacy's procedures
Answer: B
Rationale: ICH E6(R2) 5.13.3 states the sponsor is responsible for supply, storage,
and final disposition of investigational product. 21 CFR 312.59 requires sponsors
to assure return or proper disposition of unused supplies. Sites must follow the
sponsor's written procedures for reconciliation, return, or destruction, not IRB or
pharmacy processes .
5. Which of the following is one of the responsibilities of an investigator who is
NOT a sponsor?
,A) Ensuring that all participating investigators are promptly informed of
significant new adverse events
B) Reporting serious adverse events to the applicable regulatory agency
C) Ensuring proper monitoring of an investigation at all investigational sites
D) Maintaining control of the investigational product
Answer: D
Rationale: For non-sponsor investigators, responsibilities are limited to site-level
conduct and product accountability. ICH E6(R2) 4.6.1 states responsibility for
investigational product accountability at the trial site rests with the
investigator/institution. 21 CFR 312.61 requires the investigator to administer
investigational drugs only to subjects under their supervision and maintain control.
The other options are sponsor responsibilities: reporting SAEs to FDA is a sponsor
duty; monitoring at all sites is sponsor responsibility; disseminating safety updates
is sponsor's role .
6. The CCRP certification examination content is organized into which major
content areas?
A) Research Study Start-Up, Research Study Implementation, Research Study
Closure
B) Regulatory Affairs, Clinical Monitoring, Data Management
C) Informed Consent, Adverse Event Reporting, Protocol Development
D) FDA Regulations, ICH Guidelines, Ethical Principles
Answer: A
Rationale: The SOCRA CCRP exam outline specifies three major content areas:
Research Study Start-Up (40% of exam), Research Study Implementation (45%),
and Research Study Closure (10-15%). These domains reflect the comprehensive
job/task analysis conducted by SOCRA .
7. How many scored questions are on the SOCRA CCRP certification
examination?
A) 100
B) 130
C) 30
D) 150
Answer: A
Rationale: The CCRP examination consists of 130 multiple choice questions total,
but 30 of these are "beta test" unscored questions. The remaining 100 questions are
scored. To pass, candidates must correctly answer 71 of the 100 scored questions .
8. What is the purpose of the 30 unscored "beta test" questions on the CCRP exam?
, A) To increase the difficulty of the exam
B) To evaluate the psychometric soundness of each test item for future exams
C) To identify candidates who are guessing
D) To provide bonus points to candidates
Answer: B
Rationale: The 30 unscored questions are "beta test" questions that do not affect
the candidate's score. These items are not identified to the candidate. The data
collected on the unscored items is used to evaluate the psychometric soundness of
each CCRP test item for future examination development .
9. The passing score for the CCRP certification examination is determined by
which method?
A) Fixed percentage method
B) Modified Angoff Method
C) Standard deviation method
D) Norm-referenced method
Answer: B
Rationale: The passing score is determined by a panel of experts using the
"Modified Angoff Method". To achieve a passing score, candidates must correctly
answer 71 of the 100 scored questions .
10. Which of the following documents is the foundation for ethical principles in
clinical research, as referenced in the CCRP exam content?
A) The Health Insurance Portability and Accountability Act (HIPAA)
B) The Code of Federal Regulations (CFR)
C) The Belmont Report
D) The Common Rule
Answer: C
Rationale: The CCRP exam assesses knowledge of ethical principles with
foundation in the Nuremberg Code, Belmont Report, and Declaration of Helsinki.
The Belmont Report is a foundational document establishing ethical principles for
research involving human subjects .
11. According to the CCRP exam content outline, which activity falls under the
Research Study Start-Up domain?
A) Manage research study product
B) Archive research study records
C) Coordinate the development of initial research study protocol
D) Perform/participate in a research study audit
Answer: C
ACTUAL QUESTIONS AND CORRECT ANSWERS
WITH RATIONALE LATEST UPDATE ALREADY
GRADED A+ ASSURED PASS
This comprehensive question bank of 300 unique, multiple-choice questions is
meticulously designed for the SOCRA CCRP certification exam, covering all
major content domains including Research Study Start-Up (40%),
Implementation (50%), and Closure (10%). It rigorously tests knowledge of
ICH GCP E6(R2), FDA regulations (21 CFR Parts 11, 50, 56, 312, 812),
ethical principles from the Belmont Report and Declaration of Helsinki,
informed consent, adverse event reporting, investigational product
accountability, monitoring, and essential documentation. Each question
includes a correct answer and detailed rationale, providing deep conceptual
understanding and exam-style practice for successful certification
preparation.
1. The sponsor withdrew an IND due to safety concerns. Who must be notified
promptly, in addition to the FDA?
A) Site coordinator only
B) Investigational pharmacies only
C) OHRP only
D) Reviewing IRBs/IECs and all participating investigators
Answer: D
Rationale: According to 21 CFR 312.56(d), if an IND is withdrawn for safety, the
sponsor must notify the FDA and all participating investigators, who in turn notify
their reviewing IRBs/IECs. This ensures subjects are protected and sites stop
enrollment promptly .
2. A coordinator for an ongoing industry-sponsored, multi-site Phase II clinical
trial is taking an unexpected, long-term medical absence. The trial site retains
coordinator services from an external source to support clinical trial activities.
According to ICH GCP E6(R2), who is responsible for implementing procedures
to ensure the integrity of the clinical trial-related duties?
A) The sponsor
B) The investigator/institution
,C) The IRB/IEC
D) The external source
Answer: B
Rationale: The investigator/institution bears responsibility for site conduct,
oversight of delegated tasks, and ensuring qualified, trained staff regardless of
employment source. ICH E6(R2) 4.1.1 requires the investigator to be qualified and
have adequate resources, and 4.1.5 requires ensuring all assisting persons are
adequately informed about the protocol and their duties. Section 4.2.5 states the
investigator may delegate tasks but retains responsibility for the conduct of the trial
at the site .
3. In accordance with the CFR, for at least how many years after the completion of
a study must the clinical investigator provide the sponsor with relevant changes to
financial information?
A) One year
B) Two years
C) Three years
D) Five years
Answer: A
Rationale: 21 CFR 54.4(b) requires sponsors to collect financial disclosure
information before a study begins and for one year following completion. 21 CFR
54.6(e) requires clinical investigators to update financial disclosure information
during the study and for one year following completion .
4. During an IND study closeout, a monitor discovered remaining investigational
product. Which procedures must be followed for disposition?
A) IRB/IEC's procedures
B) Sponsor's procedures
C) Regulatory authority's procedures
D) Dispensing pharmacy's procedures
Answer: B
Rationale: ICH E6(R2) 5.13.3 states the sponsor is responsible for supply, storage,
and final disposition of investigational product. 21 CFR 312.59 requires sponsors
to assure return or proper disposition of unused supplies. Sites must follow the
sponsor's written procedures for reconciliation, return, or destruction, not IRB or
pharmacy processes .
5. Which of the following is one of the responsibilities of an investigator who is
NOT a sponsor?
,A) Ensuring that all participating investigators are promptly informed of
significant new adverse events
B) Reporting serious adverse events to the applicable regulatory agency
C) Ensuring proper monitoring of an investigation at all investigational sites
D) Maintaining control of the investigational product
Answer: D
Rationale: For non-sponsor investigators, responsibilities are limited to site-level
conduct and product accountability. ICH E6(R2) 4.6.1 states responsibility for
investigational product accountability at the trial site rests with the
investigator/institution. 21 CFR 312.61 requires the investigator to administer
investigational drugs only to subjects under their supervision and maintain control.
The other options are sponsor responsibilities: reporting SAEs to FDA is a sponsor
duty; monitoring at all sites is sponsor responsibility; disseminating safety updates
is sponsor's role .
6. The CCRP certification examination content is organized into which major
content areas?
A) Research Study Start-Up, Research Study Implementation, Research Study
Closure
B) Regulatory Affairs, Clinical Monitoring, Data Management
C) Informed Consent, Adverse Event Reporting, Protocol Development
D) FDA Regulations, ICH Guidelines, Ethical Principles
Answer: A
Rationale: The SOCRA CCRP exam outline specifies three major content areas:
Research Study Start-Up (40% of exam), Research Study Implementation (45%),
and Research Study Closure (10-15%). These domains reflect the comprehensive
job/task analysis conducted by SOCRA .
7. How many scored questions are on the SOCRA CCRP certification
examination?
A) 100
B) 130
C) 30
D) 150
Answer: A
Rationale: The CCRP examination consists of 130 multiple choice questions total,
but 30 of these are "beta test" unscored questions. The remaining 100 questions are
scored. To pass, candidates must correctly answer 71 of the 100 scored questions .
8. What is the purpose of the 30 unscored "beta test" questions on the CCRP exam?
, A) To increase the difficulty of the exam
B) To evaluate the psychometric soundness of each test item for future exams
C) To identify candidates who are guessing
D) To provide bonus points to candidates
Answer: B
Rationale: The 30 unscored questions are "beta test" questions that do not affect
the candidate's score. These items are not identified to the candidate. The data
collected on the unscored items is used to evaluate the psychometric soundness of
each CCRP test item for future examination development .
9. The passing score for the CCRP certification examination is determined by
which method?
A) Fixed percentage method
B) Modified Angoff Method
C) Standard deviation method
D) Norm-referenced method
Answer: B
Rationale: The passing score is determined by a panel of experts using the
"Modified Angoff Method". To achieve a passing score, candidates must correctly
answer 71 of the 100 scored questions .
10. Which of the following documents is the foundation for ethical principles in
clinical research, as referenced in the CCRP exam content?
A) The Health Insurance Portability and Accountability Act (HIPAA)
B) The Code of Federal Regulations (CFR)
C) The Belmont Report
D) The Common Rule
Answer: C
Rationale: The CCRP exam assesses knowledge of ethical principles with
foundation in the Nuremberg Code, Belmont Report, and Declaration of Helsinki.
The Belmont Report is a foundational document establishing ethical principles for
research involving human subjects .
11. According to the CCRP exam content outline, which activity falls under the
Research Study Start-Up domain?
A) Manage research study product
B) Archive research study records
C) Coordinate the development of initial research study protocol
D) Perform/participate in a research study audit
Answer: C
